Synergism between long-acting bromocryptine microcapsules and cyclosporine A in the prevention of various autoimmune diseases in rats

Experientia

Volumn 52, Issue 9, 1996, Pages 892-899

  Neidhart, M ^a  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

Adjuvant arthritis; Bromocryptine; Cyclosporine A; Diabetes mellitus; Experimental allergic uveitis; Periarteritis nodosa; Prolactin

Indexed keywords

BROMOCRIPTINE; CYCLOSPORIN A; FREUND ADJUVANT; LONG ACTING DRUG; PLACEBO;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DRUG THERAPY; FEMALE; INTRAMUSCULAR DRUG ADMINISTRATION; LEUKOCYTOSIS; MALE; MICROCAPSULE; NONHUMAN; POLYARTERITIS NODOSA; PREVENTION; RAT; SPLENOMEGALY; SUBCUTANEOUS DRUG ADMINISTRATION; UVEITIS; WEIGHT REDUCTION;

ANIMALIA;

EID: 0029838388     PISSN: 00144754     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01938877     Document Type: Article

References (31)

1. Pearson C. M. (1979) Arthritis in animals. In: Arthritis and Allied Conditions: A Textbook of Rheumatology, pp. 308-319, McCarty D. J. (eds.), Lea & Febiger, Philadelphia
2. Neidhart M. and Larson D. F. (1990) Freund's complete adjuvant induced ornithine decarboxylase activity in the central nervous system of male rats and triggered the release of pituitary hormones. J. Neuroimmun. 26: 97-105
3. Neidhart M. and Flückiger E. W. (1992) Hyperprolactinemia in hypophysectomized or intact male rats and the development of adjuvant arthritis. Immunology 77: 449-455
4. Berczi I., Nagy E., Asa S. L. and Kovacs K. (1984) The influence of pituitary hormones on adjuvant arthritis. Arthritis Rheum. 27: 682-688
5. Neidhart M. (1989) Bromocriptine microcapsules inhibit ornithine decarboxylase activity induced by Freund's complete adjuvant in lymphoid tissues of male rats. Endocrinology 125: 2846-2852
6. Russell D. H. (1985) Ornithine decarboxylase: a key regulatory enzyme in normal and neoplastic growth. Drug Metab. Rev. 16: 1-88
7. Nussenblatt R. B., Rodrigues M. M., Wacker W. B., Cevario S. J., Salinas-Carmona M. C. and Gery I. (1981) Cyclosporin A: inhibition of experimental autoimmune uveitis in Lewis rats. J. Clin. Invest. 67: 1228-1231
8. Nussenblatt R. B., Caspi R. R., Dinning W. J., Palestine A. G., Hiestand P. and Borel J. (1986) A comparison of the effectiveness of cyclosporine A, D and G in the treatment of experimental autoimmune uveitis in rats. J. Immunopharmacol. 8: 427-435
9. Palestine A. G., Muellenberg-Coulombre C. G., Kim M. K., Gelato M. C. and Nussenblatt R. B. (1987) Bromocriptine and low dose cyclosporine in the treatment of experimental autoimmune uveitis in the rat. J. Clin. Invest. 79: 1078-1081
10. Hedner L. P. and Bynke G. (1985) Endogenous iridocyclitis relieved during treatment with bromocryptine. Am. J. Ophthalmol. 100: 618-619
11. Weber G., Neidhardt M., Frey H., Galle K. and Geiger A. (1981) Treatment of psoriasis with bromocriptin. Arch. Dermatol. Res. 271: 437-439
12. Wigley R. D. (1970) The aetiology of Polyartheritis nodosa: a review. N. Z. Med. J. 71: 151-158
13. Cutts J. H. (1966) Vascular lesions resembling polyarteritis nodosa in rats undergoing prolonged stimulation with oestrogen. Br. J. Exp. Path. 47: 401-404
14. Griffith, R. W. (1977) Bromocriptine and uterine neoplasia. Br. J. Med. 2: 1605
15. Mahon J. L., Gunn H. C., Stobie K., Gibson C., Dupre J. and Stiller C. R. (1988) The effect of bromocryptine and cyclosporine on spontaneous diabetes in BB rats. Transplant. Proc. 3/Suppl. 4: 197-200
16. Zierhut M., Thiel H. J., Pleyer U., Waetjen R. and Weidle E. G. (1991) Bromocriptine in therapy of chronic recurrent anterior uveitis. Fortschr. Ophthalmol. 88: 161-164
17. Blank M., Palestine A., Nussenblatt R. and Shoenfeld Y. (1990) Down-regulation of autoantibody levels of cyclosporine and bromocryptine treatment in patients with uveitis. Clin. Immunol. Immunopathol. 54: 87-97
18. Neidhart M. (1996) Elevated serum prolactin or elevated prolactin/cortisol ratio are associated with autoimmune processes in systemic lupus erythematosus and other connective tissue diseases. J. Rheumatol. 23: 476-481
19. Hawkins T. A., Gala R. R. and Dunbar J. C. (1994) Prolactin modulates the incidence of diabetes in male and female NOD mice. Autoimmunity 18: 155-162
20. Klaus G. G. B. and Chisholm P. M. (1986) Does cyclosporine act in vivo as it does in vitro? Immunol. Today 7: 101-103
21. Atkison P. R., Mahon J. L., Dupre J., Stiller C. R., Jenner M. R., Paul T. L. and Momah C. I. (1990) Interaction of bromocryptine and cyclosporine in insulin dependent diabetes mellitus: results from the Canadian open study. J. Autoimmun. 3: 793-799
22. Hiestand P. C., Mekler P., Nordmann R., Grieder A. and Permmongkol C. (1986) Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine. Proc. Natl. Acad. Sci. USA 83: 2599-2603
23. Russell D. H., Larson D. F., Cardon S. B. and Copeland J. G. (1984) Cyclosporine inhibits prolactin induction of ornithine decarboxylase in rat tissues. Mol. Cell. Endocrinol. 35: 159-166
24. Gore-Langton R. E. (1985) Cyclosporine directly affects steroid production by rat granulosa cells. Endocrinology 116 (Suppl.): 352
25. Cardon S. B., Larson D. F. and Russell D. H. (1984) Rapid elevation of rat serum prolactin concentration by cyclosporine, a novel immunosuppressive drug. Biochem. Biophys. Res. Commun. 120: 614-618
26. Morikawa K., Oseko F. and Morikawa S. (1994) Immunosuppressive activity of bromocryptine on human T lymphocyte function in vitro. Clin. Exp. Immunol. 95: 514-518
27. Ptachcinski R. J., Burckart G. J. and Venkataramanan R. (1986) Cyclosporine concentration determinations for monitoring and pharmacokinetic studies. J. Clin. Pharmacol. 26: 358-366
28. Lemaire M., Maurer G. and Wood A. J. (1986) Cyclosporin. Pharmacokinetics and metabolism. Prog. Allergy 38: 93-107
29. Peyronneau M. A., Delaforge M., Riviere R., Renaud, J. P. and Mansuy D. (1994) High affinity of ergopeptides for cytochromes P450 3A: importance of their peptide motety for P450 recognition and hydroxylation of bromocryptine. Eur. J. Biochem. 223: 947-956
30. Collier S. J., Calne R. Y., White D. J. G., Winters S. and Thiru S. (1986) Blood levels and nephrotoxicity of cyclosporin A and G in rats. Lancet 1: 216
31. Kahan B. D., Ried M. and Newberger J. (1983) Pharmacokinetics of cyclosporine in human renal transplantation. Transplant. Proc. 15: 446-453